THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA
期刊论文会议论文
编号：
1bdc8126-4a12-4419-b402-17a7bf905ac1
作者：
Wang, V. W.[1]Li, Z.[2]
语种：
English
期刊：
VALUE IN HEALTHISSN：1098-30152018 年21 卷(S37 - S37) ; OCT
收录：
推荐引用方式 GB/T 7714：
Wang V. W.,Li Z., et al. THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA [J].VALUE IN HEALTH,2018,21:S37-S37.
APA：
Wang V. W.,Li Z..(2018).THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA .VALUE IN HEALTH,21:S37-S37.
MLA：
Wang V. W., et al. "THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA" .VALUE IN HEALTH 21(2018):S37-S37.
(8.0+极速模式)